Company: ATRA
Filing Date: 2025-06-11
Form Type: 8-K
Source: 0001193125-25-139150
Chunk: 0

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-06-11
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 10, 2025, Atara Biotherapeutics, Inc. (the “ Company”) held its 2025 annual meeting of stockholders (the “ Annual Meeting”). The following is a brief description of each matter voted upon at the Annual Meeting, as well as the number of votes cast for or against each matter and the number of abstentions and broker non-voteswith respect to each matter. A more complete description of each matter is described in more detail in the Company’s definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on April 28, 2025 (the “ Proxy Statement”).